factual
Harm Evidence Is Mostly First-Person Anecdotes
FDA approval mainly requires two positive RCTs showing benefit over placebo or competitor, with thin safety data at that stage; the vast majority of harm evidence comes only after approval, and that post-approval evidence amounts to a collection of first-person anecdotes uploaded to databases, with carefully controlled randomized harm trials being rare.
factualpending
Speaker
Jacob StegengaEvidence Quote
“The vast, vast majority of evidence that we get on the harmful side of exit[?] drugs occurs after the drug has been approved for public consumption. And at that point, there's no incentive to do any more careful randomized trials.”
Created: 6/13/2026, 12:09:58 AM
Your notes
Loading notes...